
Keywords: AmB; amphotericin B; ITZ; itraconazole; SLNs; solid lipid nanoparticles; NLCs; nanostructured lipid carriers; NE; Nanoemulsion; NPs; nanoparticles; AIDS; acquired immune deficiency syndrome; ABLC; AmB lipid complex; UDL; ultradeformable liposomes; DMVs; d